Physician profile
Angela Eakels
NPI 1659863843
$5,092.81
in general payments reported to CMS, 2019-2025
14 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $208 · 2023: $1,471 · 2024: $1,629 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,623 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,622.59 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,674.66 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,023.91 | 2021-2025 | Yeztugo |
| Merck Sharp & Dohme LLC | $421.71 | 2022-2025 | Pifeltro, Delstrigo, Dificid |
| Janssen Biotech, INC. | $409.49 | 2021-2023 | Symtuza |
| Theratechnologies INC. | $180.26 | 2023-2025 | Trogarzo, Egrifta, Egrifta Sv |
| Emd Serono, INC. | $107.96 | 2023-2025 | Serostim |
| Hologic Sales and Service, LLC | $88.48 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $59.21 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $38.01 | 2023 | Symtuza |
| Napo Pharmaceuticals INC | $20.34 | 2025 | Mytesi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.82 | 2024 | Xifaxan |
| Lilly USA, LLC | $19.05 | 2025 | Zepbound, Mounjaro |
| Shield Therapeutics INC | $15.54 | 2025 | |
| Pfizer INC. | $14.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Eakels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.